title: Triptans.
abstract: Triptans are potent serotonin (5-HT) 1B/1D receptor agonists used to abort and treat migraine headaches. Although the triptans share pharmacodynamic characteristics at 5-HT(1B/1D) receptors, they differ pharmacokinetically. This column reviews how the triptans are metabolized. Generally, the triptans are metabolized by phase I monoamine oxidases (MAOs) and by various cytochrome p450 enzymes. However, each triptan has a unique metabolic profile, leading to significant differences in each triptan's potential for drug-drug interactions. These differences are detailed in this review.
authors.affiliation: Center for Geriatric Psychiatry, Tuality Forest Grove Hospital, Forest Grove, OR 97116. scott.armstrong@tuality.org
authors.forename: Scott C
authors.initials: SC
authors.lastname: Armstrong
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Cozza
mesh_terms: D004347:Drug Interactions; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
chemical_list: D017366:Serotonin Receptor Agonists